Total synthesis of (+)-cortistatin A
Total synthesis of (+)-cortistatin A
复制标题
DOI:
10.1002/anie.200803550
复制
发表时间:
2008-01-01
影响因子:
16.6
通讯作者:
Chen, David Y-K.
中科院分区:
文献类型:
--
作者:
Nicolaou, K. C.;Sun, Ya-Ping;Chen, David Y-K.
Angiogenesis is an important physiological phenomenon whose imbalance may result in several disease states, including malignant, inflammatory, ischaemic, infectious, and immune disorders.[1] The inhibition of angiogenesis has been considered for some time as an attractive way to improve such conditions. With the recent introduction of the first antiangiogenic agents to treat cancer and blindness, the search for new inhibitors of angiogenesis assumed a new level of priority and urgency.In 2006 [2] and 2007,[3, 4] the Kobayashi research group disclosed a series of novel steroidal alkaloids possessing remarkable anti-angiogenic properties that endow them with potent anti-proliferative activities. Isolated from the sponge Corticium simplex, and named cortistatins, these molecules boast a heptacyclic skeleton featuring an oxabicyclo-[3, 2, 1] octene and, some, an isoquinoline structural motif. From the 11 naturally occurring members of the cortistatin family, cortistatinA (1, Scheme1; IC50= 1.8 nm against